Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
- First Posted Date
- 2011-04-13
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT01334879
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
- First Posted Date
- 2008-09-10
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00750399
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00456495
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
News
No news found